Angela Cochran
@acochran12733.bsky.social
Publisher at ASCO; football, softball, and theater mom; former president of SSP and CSE. Scholarly Kitchen chef. Girl Scout leader. All posts my own unless stolen from someone way smarter. #oncsky
JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social
September 24, 2025 at 12:51 AM
JCO Journals are now on BlueSky! Give us a follow. @jco-asco.bsky.social @pamelakunzmd.bsky.social @ethicsdoctorp.bsky.social @hemoncwarner.bsky.social @kvanloonmd.bsky.social
Might Google Scholar be headed to the Google Graveyard? hannahshelley.neocities.org/blog/2025_08...
Google Scholar Is Doomed
Academia built entire careers on a free Google service with zero guarantees. What could go wrong?
hannahshelley.neocities.org
September 5, 2025 at 11:03 AM
Might Google Scholar be headed to the Google Graveyard? hannahshelley.neocities.org/blog/2025_08...
Reposted by Angela Cochran
A pleasure and an honor to join @fumikochino.bsky.social & Dr. Ethan Ludmir in this @ascocancer.bsky.social conversation on incomplete reporting and toxicity- minimizing language in oncology! 💗
“When choosing cancer therapies, people should not have to choose between being alive & living”
Toxicity minimizing language ("safe” & “tolerable”) are subjective & can downplay QOL limiting side effects from treatment.
🚨New @ascocancer.bsky.social Podcast is live today!
@coffeemommy.bsky.social
Toxicity minimizing language ("safe” & “tolerable”) are subjective & can downplay QOL limiting side effects from treatment.
🚨New @ascocancer.bsky.social Podcast is live today!
@coffeemommy.bsky.social
Incomplete Reporting and Toxicity-Minimizing Language in Oncology | Podcast | ASCO Publications
There is often a disconnect in toxicity assessment between what is reported on clinical trials as being “well tolerated” and the lived experience of taking a treatment for patients. Toxicity minimizin...
ascopubs.org
July 28, 2025 at 11:53 PM
A pleasure and an honor to join @fumikochino.bsky.social & Dr. Ethan Ludmir in this @ascocancer.bsky.social conversation on incomplete reporting and toxicity- minimizing language in oncology! 💗
I don't agree with their peer review model, but the premise here is correct. There are rules of indexing and citation counting that are keeping journals from transforming into modern publication systems.
“Journals and peer review are unlikely to change for the better if the companies that operate scientific indexes and citation databases continue to stifle innovation.”
Read our guest post in DORA: buff.ly/EGDbskH
Read our guest post in DORA: buff.ly/EGDbskH
July 31, 2025 at 8:30 PM
I don't agree with their peer review model, but the premise here is correct. There are rules of indexing and citation counting that are keeping journals from transforming into modern publication systems.
Reposted by Angela Cochran
FDA’s cancer review team overseeing breast and gynecological products has lost about 1/3 of its medical review staff and the malignant heme group will lose about 2/3 of its medical review staff—all to voluntary resignations clustered among seasoned reviewers
insights.citeline.com/pink-sheet/a...
insights.citeline.com/pink-sheet/a...
July 26, 2025 at 1:57 PM
FDA’s cancer review team overseeing breast and gynecological products has lost about 1/3 of its medical review staff and the malignant heme group will lose about 2/3 of its medical review staff—all to voluntary resignations clustered among seasoned reviewers
insights.citeline.com/pink-sheet/a...
insights.citeline.com/pink-sheet/a...
Reposted by Angela Cochran
Reposted by Angela Cochran
In an unprecedented move, the NIH will soon disinvite dozens of scientists who were about to take positions on advisory councils that make final decisions on grant applications for the US agency, Nature has learnt.
go.nature.com/3TEw7GN
go.nature.com/3TEw7GN
Exclusive: NIH to dismiss dozens of grant reviewers to align with Trump priorities
The move would undo years of work, leaving advisory councils understaffed, and without the full expertise needed for reviews.
go.nature.com
July 14, 2025 at 10:12 PM
In an unprecedented move, the NIH will soon disinvite dozens of scientists who were about to take positions on advisory councils that make final decisions on grant applications for the US agency, Nature has learnt.
go.nature.com/3TEw7GN
go.nature.com/3TEw7GN
Agree. At least a decade of pushing our kids to STEM only. Result: few can critically read or write, entry level computer science/coding jobs were the 1st to get cut with AI, decrease in kids wanting to be physicians.
Decades of mechanistic talk about university degrees as if they were bundles of 'skills' and 'prep' are about to be proved completely wrong (obviously). Want to get a real boost? Do History or English.
July 13, 2025 at 1:42 PM
Agree. At least a decade of pushing our kids to STEM only. Result: few can critically read or write, entry level computer science/coding jobs were the 1st to get cut with AI, decrease in kids wanting to be physicians.
Reposted by Angela Cochran
Yep. Prestige costs money to create (literally: highly-selective journals are more expensive to run in part because of their selectivity, not to mention their staff). And, if gold OA is to be the model, then author or their funders are agreeing to pay per paper for that prestige.
July 11, 2025 at 1:55 PM
Yep. Prestige costs money to create (literally: highly-selective journals are more expensive to run in part because of their selectivity, not to mention their staff). And, if gold OA is to be the model, then author or their funders are agreeing to pay per paper for that prestige.
Reposted by Angela Cochran
We have life saving cancer drugs and life threatening shortages. See our new op ed with potential solutions in @jco-asco.bsky.social
@lymphomadoc.bsky.social
@ascocancer.bsky.social
ascopubs.org/doi/10.1200/...
@lymphomadoc.bsky.social
@ascocancer.bsky.social
ascopubs.org/doi/10.1200/...
July 3, 2025 at 12:58 AM
We have life saving cancer drugs and life threatening shortages. See our new op ed with potential solutions in @jco-asco.bsky.social
@lymphomadoc.bsky.social
@ascocancer.bsky.social
ascopubs.org/doi/10.1200/...
@lymphomadoc.bsky.social
@ascocancer.bsky.social
ascopubs.org/doi/10.1200/...
Reposted by Angela Cochran
There's also a helpful criticism here that, if we have to constantly and meticulously double check the work of AI then is it a tool that really saves us time and effort? And, given that cost/benefit ratio, what are the actual use cases that make using it worthwhile?
June 23, 2025 at 1:48 PM
There's also a helpful criticism here that, if we have to constantly and meticulously double check the work of AI then is it a tool that really saves us time and effort? And, given that cost/benefit ratio, what are the actual use cases that make using it worthwhile?
Reposted by Angela Cochran
‼️ #ASCO25 simultaneous publication by Jacobs et al:
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
May 30, 2025 at 6:00 PM
‼️ #ASCO25 simultaneous publication by Jacobs et al:
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...
Reposted by Angela Cochran
For breaking news and expert analysis during #ASCO25, turn to #ASCODailyNews! During and after the Meeting, ASCO Daily News has coverage of all the practice-changing research being presented. Bookmark us now: dailynews.ascopubs.org/meetings/asc... #oncsky
May 30, 2025 at 2:27 PM
For breaking news and expert analysis during #ASCO25, turn to #ASCODailyNews! During and after the Meeting, ASCO Daily News has coverage of all the practice-changing research being presented. Bookmark us now: dailynews.ascopubs.org/meetings/asc... #oncsky
Reposted by Angela Cochran
The @ascocancer.bsky.social Ed Book is the highest-quality, peer-reviewed, FREE #oncology #MedEd ever. Whether or not you’re at #ASCO25, don’t miss this resource, #OncSky #MedSky, #MedStudentSky! Drop a 📌 in the comments to bookmark the link for later.
ascopubs.org/toc/edbk/cur...
#OncoAlert
ascopubs.org/toc/edbk/cur...
#OncoAlert
May 30, 2025 at 2:39 PM
The @ascocancer.bsky.social Ed Book is the highest-quality, peer-reviewed, FREE #oncology #MedEd ever. Whether or not you’re at #ASCO25, don’t miss this resource, #OncSky #MedSky, #MedStudentSky! Drop a 📌 in the comments to bookmark the link for later.
ascopubs.org/toc/edbk/cur...
#OncoAlert
ascopubs.org/toc/edbk/cur...
#OncoAlert
Don't miss it! #ASCODailyNews has your exclusive advanced coverage of important abstracts being presented at #ASCOAM dailynews.ascopubs.org/meetings/asc...
ASCO Annual Meeting | ASCO Daily News
The ASCO Annual Meeting is the Society's yearly gathering where oncologists unveil their latest clinical research, and ASCO Daily News has you covered before, during, and after the Meeting with in-dep...
dailynews.ascopubs.org
May 23, 2025 at 12:51 PM
Don't miss it! #ASCODailyNews has your exclusive advanced coverage of important abstracts being presented at #ASCOAM dailynews.ascopubs.org/meetings/asc...
Reposted by Angela Cochran
Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in @statnews.com
ASCO and Google create ‘walled garden’ AI tool for doctors to query group’s guidelines
ASCO and Google Cloud's AI tool is meant to help oncologists query just its trusted cancer treatment guidelines, without extraneous information.
www.statnews.com
May 21, 2025 at 5:55 PM
Just announced: ASCO and Google Cloud launch the ASCO Guidelines Assistant, an AI tool for fast access to ASCO's trusted and expert-developed clinical cancer guidelines. Read more in @statnews.com
Exciting news! Making ASCO expert, evidence-based treatment guidelines easier than ever to access.
The ASCO Guidelines Assistant is built for how oncologists work today. Powered by AI and developed in partnership with Google Cloud, it delivers fast, evidence-based answers drawn exclusively from ASCO’s clinical practice guidelines.
Explore More: brnw.ch/21wSQGp
Explore More: brnw.ch/21wSQGp
May 23, 2025 at 1:02 AM
Exciting news! Making ASCO expert, evidence-based treatment guidelines easier than ever to access.
‼️ #ASCO25 simultaneous publication by Tolani et al:
Development and Validation of An Adapted Tool to Measure Health-Related Social Needs for The Prostate Cancer Population in Nigeria.
Read full article: brnw.ch/21wSRt9
Development and Validation of An Adapted Tool to Measure Health-Related Social Needs for The Prostate Cancer Population in Nigeria.
Read full article: brnw.ch/21wSRt9
May 23, 2025 at 1:00 AM
Reposted by Angela Cochran
Excellent review article by @ptarantinomd.bsky.social on redefining Her-2 testing @ethicsdoctorp.bsky.social @acochran12733.bsky.social ascopubs.org/doi/10.1200/... @oncoalert.bsky.social
May 13, 2025 at 10:06 PM
Excellent review article by @ptarantinomd.bsky.social on redefining Her-2 testing @ethicsdoctorp.bsky.social @acochran12733.bsky.social ascopubs.org/doi/10.1200/... @oncoalert.bsky.social
Reposted by Angela Cochran
Excellent review article by @bldcancerdoc.bsky.social Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @oncoalert.bsky.social
April 19, 2025 at 11:42 PM
Excellent review article by @bldcancerdoc.bsky.social Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @oncoalert.bsky.social
Reposted by Angela Cochran
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice
ascopubs.org
April 17, 2025 at 11:51 AM
Humanizing Oncology Care: A Strategic Imperative | JCO Oncology Practice ascopubs.org/doi/10.1200/...
Reposted by Angela Cochran
Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @ascocancer.bsky.social
April 12, 2025 at 12:26 PM
Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @ascocancer.bsky.social
Reposted by Angela Cochran
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @ascocancer.bsky.social
April 12, 2025 at 12:13 PM
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @ascocancer.bsky.social
Reposted by Angela Cochran
Disparities in Endometrial Cancer Mortality: Will Increasing Use of Targeted Therapies Widen the Gap? | JCO Oncology Practice ascopubs.org/doi/pdf/10.1... @ascocancer.bsky.social @acochran12733.bsky.social
ASCO Publications
ascopubs.org
March 29, 2025 at 10:11 PM
Disparities in Endometrial Cancer Mortality: Will Increasing Use of Targeted Therapies Widen the Gap? | JCO Oncology Practice ascopubs.org/doi/pdf/10.1... @ascocancer.bsky.social @acochran12733.bsky.social
Patterns of Homologous Repair Deficiency and BRCA1/2 Testing of Ovarian and Breast Cancers: A Real-World Study of Patients in Community Health Settings in the United States ascopubs.org/doi/10.1200/... #JCOOA #OpenAccess
ASCO Publications
ascopubs.org
March 19, 2025 at 1:11 AM
Patterns of Homologous Repair Deficiency and BRCA1/2 Testing of Ovarian and Breast Cancers: A Real-World Study of Patients in Community Health Settings in the United States ascopubs.org/doi/10.1200/... #JCOOA #OpenAccess